ANTIMICROBIAL COMPLEXES
20230232825 · 2023-07-27
Inventors
- Lino Da Silva Ferreira (Coimbra, PT)
- David JOSÉ ROXO BOTEQUIM (Achete, PT)
- Joã REINA MAIA E SILVA (Leça de Balio, PT)
Cpc classification
A01N2300/00
HUMAN NECESSITIES
A01N25/34
HUMAN NECESSITIES
A01N25/34
HUMAN NECESSITIES
A01N2300/00
HUMAN NECESSITIES
International classification
Abstract
The invention relates to an antimicrobial surfactant complexed with a nanomaterial. The surfactant can be a quaternary ammonium cationic surfactant which is coated on the surface of a nanomaterial such as a silica nanoparticle or a carbon nanotube.
Claims
1. An antimicrobial nanomaterial complex comprising a surfactant and a nanomaterial.
2. An antimicrobial nanomaterial complex as claimed in claim 1, wherein the surfactant is an amphiphilic polycation.
3. An antimicrobial nanomaterial complex as claimed in claim 2, wherein the amphiphilic polycation is a quaternary ammonium cationic surfactant.
4. An antimicrobial nanomaterial complex as claimed in claim 3, wherein the quaternary ammonium cationic surfactant is selected from the group consisting of: dodecyltrimethylammonium bromide (DTAB), didodecyldimethylammonium bromide (DDAB), tridodecylmethylammonium chloride (TMAC), ditetradecyldimethylammonium bromide (DTDAB), dihexadecyldimethylammonium bromide (DHDAB) and dioctadecyldimethylammonium bromide (DODAB).
5. An antimicrobial nanomaterial complex as claimed in claim 1, wherein the nanomaterial is a silica nanoparticle or a carbon nanotube.
6. An antimicrobial nanomaterial complex as claimed in claim 5, wherein the nanomaterial is a single-walled carbon nanotube.
7. An antimicrobial nanomaterial complex as claimed in claim 1, wherein the nanomaterial has at least one dimension of 500 nm or less.
8. An antimicrobial nanomaterial complex as claimed in claim 7, wherein the nanomaterial is a nanoparticle having at least one dimension of 290 nm or less.
9. An antimicrobial nanomaterial complex as claimed in claim 1, having antiviral activity.
10. A method of preparing the antimicrobial nanomaterial complex of claim 1, comprising the steps of: providing a solution of surfactant having a concentration above its critical micelle concentration; and adding the solution to a nanomaterial suspension.
11. Use of an antimicrobial nanomaterial complex as claimed in claim 1 as an antimicrobial coating.
12. A method of preparing an item with an antimicrobial coating, wherein the method comprises coating at least one surface or part of a surface of the item with an antimicrobial nanomaterial complex as claimed in claim 1.
13. A method of preparing an item with an antimicrobial coating as claimed in claim 12, wherein the at least one surface or part of a surface is treated with an adhesive prior to coating.
14. Use of a surfactant as an antimicrobial agent in an antimicrobial nanomaterial complex comprising a nanomaterial.
Description
[0048] The invention is now further described with reference to the following figures:
[0049]
[0050]
[0051]
[0052]
[0053]
[0054]
[0055]
[0056]
[0057]
[0058]
[0059]
[0060]
DETAILED DESCRIPTION OF THE INVENTION
[0061] The invention is directed to antimicrobial complexes comprising nanomaterials complexed with surfactants. By way of illustration only, the invention will now be fully described in the context of a didodecyldimethylammonium bromide-silica nanoparticle complex (DDAB-SNP) and a didodecyldimethylammonium bromide-carbon nanotube complex (DDAB-CNT).
Example 1: Characterisation of Bare Silica Nanoparticles (SNPs)
[0062] Commercially available silica nanoparticles of 5 nm (SNP5) and 80 nm (SNP80) in diameter were purchased from Eka Chemicals AB (Bohus, Sweden) and PlasmaChem GmbH (Berlin, Germany), respectively. The nanoparticles were characterised prior to conjugation by scanning electron microscopy, transmission electron microscopy and dynamic light scattering as detailed below. The specific surface area and the density of the particles were also determined.
[0063] 1.2.1 Scanning Electron Microscopy (SEM) Analysis
[0064] SNP5 suspended in distilled water (5 μl, 0.5 mg/ml) were deposited on 0.5 cm.sup.2 glass slides. The solvent was allowed to evaporate and the slides mounted on a SEM sample stub using conductive carbon cement. The samples were then carbon coated by plasma vapour deposition and analyzed by a Hitachi SU-70, with a STEM detector at 4 kV. Results of the SEM analysis are shown in
[0065] 1.2.2 Transmission Electron Microscopy (TEM) Analysis
[0066] For TEM analysis, a suspension of SNP80 (10 μl, 5 mg/ml in Phosphate Buffered Saline (PBS)) was spray coated on a TEM 400 mesh grid. The SNPs were then observed by 20 TEM on a FEI microscope (model TECNAI G2 20 S-TWIN) at 200 kV. Results of the TEM analysis are shown in
[0067] 1.2.3 Dynamic Light Scattering (DLS) Analysis
[0068] SNP size was determined using dynamic light scattering (DLS) via Zeta PALS Zeta Potential Analyzer and ZetaPlus Particle Sizing Software, v. 2.27 (Brookhaven Instruments Corporation). An aliquot (20 μl) of SNPs suspended in water (2 mg/ml) was added to 2 ml of PBS pH 7.4, vortexed and sonicated. All sizing measurements were performed at ca. 25° C., and all data were recorded at 90° C., with an equilibration time of 5 min. and individual run times of 60 s (5 runs per measurement). The average diameters are number-weighted, and were collected from 3 independent measurements. The zeta potential of the previous SNP suspensions was recorded in at least 6 runs with a relative residual value (measure of data fit quality) of 0.03.
[0069] 1.2.4 Specific Surface Area Measurement
[0070] The specific surface area was assessed on an ASAP 2000 instrument, using the BET isotherm model with a relative pressure range of 0.05-0.15.
[0071] 1.2.5 Density Measurement
[0072] Density of the nanoparticles was measured using helium pycnometry.
[0073] The results of the SNP characterisation are illustrated in Table 1 below.
TABLE-US-00001 TABLE 1 Table 1: Characterisation of bare SNP SNP5 SNP80 Diameter (nm) [SEM/TEM] 5.0 ± 2.0 58.3 ± 3.8 Diameter (nm) [DLS] 7.5 ± 1.7 78.9 ± 12.6 Specific Surface Area (m.sup.2g.sup.−1) 293.0 ± 3.4 218.5 ± 68.sup. [BET method] Density (g/cm.sup.3) [helium pycometry] 2.18 1.20 SNP5 were found by DLS to have a diameter of 7.5 ± 1.7 nm, corresponding to a diameter of 5.0 ± 2.0 by SEM. SNP80 were found by DLS to have a diameter of 78.9 ± 12.6 nm, corresponding to a diameter of 58.3 ± 3.8 by TEM. BET analysis established a surface area of 293.0 ± 3.4 m.sup.2g.sup.−1 for SNP5 and a surface area of 218.5 ± 68 m.sup.2g.sup.−1 for SNP80. The densities of the SNPs were 2.18 g/cm.sup.3 (SNP5) and 1.20 g/cm.sup.3 (SNP80) measured by helium pycnometry.
Example 2: Determination of Critical Micelle Concentration (CMC)
[0074] Critical Micelle Concentration (CMC) was determined for a range of surfactants, following the method described by Brito et al. ‘Determination of the critical micelle concentration of surfactants using the fluorescent probe N-phenyl-1-naphthylamine.’ Anal. Biochem 1986 (152) 250-255.
[0075] The surfactants tested were: [0076] dodecyltrimethylammonium bromide (DTAB, TCI), [0077] didodecyldimethylammonium bromide (DDAB, Sigma-Aldrich), [0078] tridodecylmethylammonium chloride (TMAC, Sigma-Aldrich), [0079] ditetradecyldimethylammonium bromide (DTDAB, TCI), [0080] dihexadecyldimethylammonium bromide (DHDAB, TCI) [0081] and dioctadecyldimethylammonium bromide (DODAB, Sigma-Aldrich).
[0082] Briefly, the surfactants were dissolved in PBS (pH 7.4), serially diluted and mixed with N-phenyl-1-naphthylamine (NPN; TCI). The fluorescence of each sample was quantified (excitation at 350 nm; emission at 420 nm) and plotted against the concentration of each surfactant. The CMC was found at the intersection of two straight lines traced on the emission intensity plot, defining the aqueous and micellar environments. The CMC values for the tested surfactants are given in Table 2 below.
Example 3: Antimicrobial Activity of Quaternary Ammonium Cationic Surfactants
[0083] To evaluate the effect of the molecular structure of quaternary ammonium cationic surfactants on their antimicrobial activity, a range of surfactants were tested against fungi and bacteria in order to determine the minimal inhibitory concentration. The surfactants tested were single-chained (DTAB), di-chained (DDAB) and tri-chained (TMAC), having 12-C length hydrocarbon chains. In addition, to evaluate the effect of chain length on antimicrobial activity, dialkyldimethylammonium bromide surfactants with variable chain lengths including 12 (DDAB), 14 (DTAB), 16 (DHDAB) and 18 (DODAB) carbon atoms were tested. These surfactants are shown in
[0084] Growth kinetics of Candida albicans ATCC 10231 (C. albicans, fungi), Staphylococcus aureus ATCC 6538 (S. aureus, gram-positive bacteria) and Escherichia coli ATCC 25922 (E. coli, gram-negative bacteria) (1×10.sup.5 cells/ml) exposed to variable concentrations (from 62.5 to 500 μg/ml for fungi and from 15.6 to 500 μg/ml for S. aureus and E. coli) of the surfactants was evaluated by absorbance at 600 nm. Results are shown in
[0085] Results are shown in Table 2.
TABLE-US-00002 TABLE 2 Critical micelle concentrations (CMCs) and minimal inhibitory concentrations (MICs) for the surfactants tested. # # CMC MIC (μg/ml) Surfactant chains carbons (μg/ml) C. albicans S. aureus E. coli DTAB 1 12 3515.1 250 31.25 62.5 DDAB 2 12 32.4 250 31.25 125 TMAC 3 12 246.2 n.d. 125 n.d. DTDAB 2 14 7.8 n.d. n.d. n.d. DHDAB 2 16 5.2 n.d. n.d. n.d. DODAB 2 18 — n.d. n.d. n.d. n.d.-not determined under the studied concentration range
[0086] With regard to E. Co/i, the toxicity ranking of all surfactants studied in this work was DTAB>DDAB>DHDAB>TMAC≈DTDAB; for C. albicans was DDAB>DHDAB>DTAB>TMAC>DTAB>DODAB, and finally for S. aureus was DDAB>DTAB>DHDAB>DODAB≈DTDAB>TMAC. DDAB is the most effective in the inhibition of C. albicans (125 μg/ml) and S. aureus (31.3 μg/ml), while DTAB is the most effective in the inhibition of E. coli (125 μg/ml). Results suggested that antimicrobial activity is higher for surfactants having two hydrocarbon chains formed by 12 carbons than for those with C-14, C-16 or C-18 chains.
Example 4: Physical Immobilization of Surfactants on SNPs
[0087] Based on the results of example 3 above, DDAB was chosen for further investigation. SNPs were mixed with aqueous solutions of DDAB at different concentrations and pHs, for varying lengths of time to facilitate absorption. Concentrations of DDAB above its CMC (32.4 μg/ml, example 2 above) were tested (i.e. 200, 500, 1000 and 2000 μg/ml for DDAB.sub.50-SNP, DDAB.sub.125-SNP, DDAB.sub.250-SNP and DDAB.sub.500-SNP, respectively). The concentrations used were 50, 125, 250 and 500 μg of DDAB per mg of SNPs (suspension of 5%, w/v) and therefore per 0.293 m.sup.2 or 0.218 m.sup.2 in case of SNP5 and SNP80, respectively (taking into account the surface areas of 293.0±3.4 m.sup.2 g.sup.−1 and 218.5±68 m.sup.2 g.sup.−1 for SNP5 and SNP80, respectively).
[0088] Specifically, aqueous suspensions of SNP5 or SNP80 (5% w/v, in (i) distilled water; (ii) 0.1M citrate/sodium citrate buffer pH 3.0 and (iii) 0.1M borate/NaOH buffer pH 9.0) were added to an aqueous solution of DDAB (50, 125, 250 and 500 μg per mg of SNPs), for variable time (30 min, 1 h, or 3 h), under vigorous magnetic stirring (800 rpm) at room temperature.
[0089] After the adsorption period, the suspension of the SNPs was centrifuged (30 min, 40,000 rpm for SNP5; 20 min, 10,000 rpm for SNP80), washed two times with distilled water and finally freeze-dried. Importantly, aqueous solutions of DDAB (i.e. without SNPs, forming vesicles with an average diameter of 57 nm and a zeta potential of 17.11±2.15 mV) centrifuged at the same velocities, did not form a pellet.
Example 5: Quantification of Immobilized Surfactant
[0090] The adsorption of DDAB to SNPs was determined by conventional and high resolution modulated Thermogravimetric Analysis (TGA).
[0091] The thermal behavior of the samples was evaluated by simultaneous thermal analysis (STA; heat-flux DSC. and TGA), by using a TA Instruments SDT Q600 equipment (thermobalance sensitivity: 0.1 g, which was previously calibrated in the range 25-1000° C. by running tin and lead as melting standards, at a heating rate of 10° C. min.sup.−1, using open alumina crucibles and a dry nitrogen purge flow of 100 ml min.sup.−1. The mass loss measured in the temperature range from 200 to 350° C. was used to calculate the percentage of surfactant adsorbed to a certain mass of SNPs.
[0092] The mass loss process was further studied in detail by high-resolution modulated thermogravimetric analysis (HiRes-M-TGA) in a TA Instruments Q500 thermogravimetric apparatus (thermobalance sensitivity: 0.1 g. The temperature calibration was performed in the range 25-1000° C. by measuring the Curie point of nickel standard. Open platinum crucibles and a dry nitrogen purge flow of 100 ml min-were used. The experiments were performed under a dynamic rate mode with a (maximum) heating rate of 2° C. min.sup.−1, a modulation period of 200 s, and a temperature amplitude of ±5° C.
[0093] The results of the thermogravimetric analysis are shown in
[0094] Depending on the initial concentration of DDAB, SNP5 was found to immobilize between 57 and 210 μg of DDAB per mg of SNP, while SNP80 was found to immobilize between 45 to 275 μg of the conjugate per mg of SNP (
[0095] The derivatives of the TGA plots in DDAB-SNP5 indicate the presence of two major peaks: the first one between 150° C. and 195° C., and the second one between 218° C. and 255° C. (
[0096] The influence of the concentration, pH and time on the physical immobilization of DDAB to SNPs was also assessed and the results are shown in
[0097] The size and the zeta potentials of the SNPs were evaluated.
[0098] According to
[0099] The range of times (30 min, 1 hr, 3 hr) (
Example 6: DRIFT Analysis
[0100] To further characterize the adsorption of DDAB to SNPs, Diffuse Reflectance Infrared Fourier Transform Spectroscopy (DRIFT) analysis was carried out. DRIFT analysis of lyophilized DDAB vesicles and of the bare and DDAB-coated SNPs was performed using a Mattson RS1 FTIR spectrometer with a Specac Selector, in the 400-4000 cm.sup.−1 range (wide band MCT detector), at 4 cm.sup.−1 resolution. The spectra were the result of 500 co-added scans for each sample, ratioed against the same number of scans for the background (ground KBr, FTIR grade from Aldrich). The samples were previously ground and mixed with KBr in appropriate proportions to obtain spectral absorbance in the range of applicability of the Kubelka-Munk transformation (Kubelka et al. ‘Ein Beitrag zur Optik der Farbanstriche.’ Z. Tech. Phys. 1931 (10) 593-601).
[0101] 6.1 Bare SNP5 and Bare SNP80
[0102] The results of the DRIFT analysis are shown in
[0103] 6.2 SNP-DDAB
[0104] To further characterize the adsorption of DDAB to SNPs, DRIFT analysis of the coated SNPs was performed.
[0105] The maximum of the νO—H band shifts considerably to lower wavenumbers upon DDAB adsorption and as DDAB concentration increases up to 250 μg/mg silica, indicating that the fraction of the more interacting hydroxyl groups increases with the DDAB load. This effect is clearer for SNP80 and suggests the involvement of OH groups as anchor sites for DDAB. However, the shift becomes very small when increasing the DDAB load to 500 μg/mg silica, which shows that further modifications at the SNP surface are negligible (
TABLE-US-00003 TABLE 3 ν.sub.asSi-O-Si band deconvolution SNP5 SNP5-DDAB.sub.50 SNP5-DDAB.sub.500 SNP80 SNP80-DDAB.sub.50 SNP80-DDAB.sub.500 LO (SiO).sub.6 {tilde over (v)}/cm.sup.−1 1231 1207 1209 1212 1212 1209 % A 2.7 22.3 21.6 21.0 19.9 21.0 LO (SiO).sub.4 {tilde over (v)}/cm.sup.−1 1184 1152 1167 1170 1172 1171 % A 33.2 20.2 8.9 9.0 6.0 4.2 TO (SiO).sub.4 {tilde over (v)}/cm.sup.−1 1112 1118 1121 1113 1111 1112 % A 30.6 10.0 29.5 57.1 66.7 62.1 TO (SiO).sub.6 {tilde over (v)}/cm.sup.−1 1055 1079 1060 1049 1048 1046 % A 33.4 47.5 40.0 12.9 7.4 12.6 δ(SiO).sub.6/cm.sup.−1 176 128 149 163 164 163 δ(SiO).sub.4/cm.sup.−1 72 34 46 57 61 59 % (SiO).sub.6 36.1 69.9 61.6 33.9 27.3 33.7 % (SiO).sub.4 63.9 30.1 38.4 66.1 72.7 66.3 ν-wavenumber of maximum absorption, cm.sup.−1; % A-percentual area; LO (SiO).sub.x-longitudinal-optic component of siloxane x-rings; TO (SiO).sub.x-transverse-optic component of siloxane x-rings; δ(SiO).sub.x-LO-TO splitting of siloxane x-rings; % (SiO).sub.x-total percentual area of siloxane x-rings.
[0106] In
[0107] Taking into account that the SNP5 are much richer in OH groups, a higher adsorption yield would be expectable for low DDAB concentrations, while the first layer is being formed (up to 125 sg/mg silica). This was confirmed by the TGA results and also by DRIFT, comparing the relative intensities of the CH.sub.2 and CH.sub.3 deformation bands versus the main silica band.
[0108] Based on the concentrations of DDAB adsorbed to SNPs and on the efficiency of the adsorption process, the ratio 250 μg of DDAB per mg of SNPs was selected (SNP-DDAB.sub.250) for further experiments.
Example 7: Immobilization of −DDAB-SNP onto a Surface
[0109] Glass coverslips were coated as described in Paulo C. et al. ‘Antifungal nanoparticles and surfaces’. Biomacromolecules 2010 (11) 2810-2817. Basically, round glass coverslips (Ø=12 mm) were initially cleaned by ultrasonication in successive 10 min steps in acetone, methanol:H.sub.2O (1:1) and chloroform. The coverslips were then placed in 24-well plates, one per well, immersed in 0.5 ml dopamine hydrochloride solution (2 mg/ml in 10 mM Tris buffer pH 8.5), shaken overnight (150 rpm orbital shaking) and finally rinsed with distilled water. The coverslips were dried and covered with a suspension of SNP5 or DDAB.sub.250-SNP5 (20 μl each, 5 mg/ml in 10 mM Tris buffer pH 8.5), dried and immersed in 0.5 ml Tris buffer overnight. This process was repeated three times. The washing water was analysed by DLS via Zeta PALS Zeta Potential Analyzer in order to assess the number of particles removed from the surface (given by the counts per second). It was possible to immobilise 222.8 and 243.9 sg/cm.sup.2 of SNP5 and DDAB.sub.250-SNP5, respectively. Because no amine or sulfhydryl groups exist in DDAB.sub.250-SNP5, π-π interactions and hydrogen bonding likely mediate the immobilization of SNPs to the polydopamine-coated surface.
Example 8: Antimicrobial Activity of DDAB-SNP
[0110] SNP5 or SNP80 coated with DDAB (SNP5-DDAB.sub.250 or SNP80-DDAB.sub.250) were tested in suspension against C. albicans, Aspergillus oryzae ATCC 46244 (A. oryzae; mold), Penicillium ochrochloron ATCC 9112 (P. ochrochloron; mold), S. aureus (bacteria gram-positive) and E. coli (bacteria gram-negative). Yeast Peptone Dextrose (YPD) and Tryptone Soy Yeast (TSY) media were used to culture yeast and bacteria, respectively.
[0111] DDAB.sub.250-SNP5 or DDAB.sub.250-SNP80 suspended in culture medium (500 μg/ml) was added to (i) 1 ml YPD media containing 1×10.sup.5 cells of C. albicans, (ii) 1 ml TSY medium containing 1×10.sup.6 cells of E. Coli or S. Aureus, or (iii) 1 ml water containing 1×10.sup.5 cells/ml of A. oryzae or P. ochrochloron spores. Cells were incubated for 6 h at 30° C. (fungi) or 37° C. (bacteria) with orbital shaking (150 rpm). Then, an aliquot of the medium was serially diluted in sterile water and plated on YPD agar plates (1% yeast extract, 2% peptone, 2% dextrose, 2% agar) or TSY agar plates (3.3% tryptic soy broth, 0.3% yeast extract, 1.7% agar). Finally, the plates were incubated at 30° C. and 37° C. for 18 h and the number of colony forming units (CFU) was counted and compared with the controls (SNP5 or SNP80) and the inoculum (prokaryotic cells incubated without SNPs). Minimum inhibitory concentrations (MICs) were determined by the broth microdilution method according to the National Committee for Clinical Laboratory Standard (for yeasts; NCCLS; M27A2E) and the Clinical and Laboratory Standards Institute (for bacteria; CLSI; M07-A8) guidelines.
[0112] To evaluate the anti-mold activity of SNP, suspensions of spores from Aspergillus or Penicillium were prepared from grown cultures on Potato Dextrose Agar (PDA) plates at 30° C. DDAB.sub.250-SNP80 suspended in sterile distilled water (500 μg/ml) was incubated with a suspension of spores (1×10.sup.5 spores/ml, in sterile distilled water) for 6 h, at 150 rpm and 30° C. At the end of the incubation, an aliquot of the medium was serially diluted in sterile distilled water and plated on PDA plates (3.3% potato dextrose broth, 1.1% agar). The plates were then incubated at 30° C. and CFU counted after 3 days and compared with the controls (SNP5 or SNP80) and the inoculum (spores without SNP).
[0113] To evaluate the biological activity of DDAB.sub.250-SNP5 or DDAB.sub.250-SNP80 against yeast, bacteria and molds in multiple challenges, the particle suspension (3 mg/ml) was centrifuged (20 min, 14,000 rpm) after the previous antimicrobial activity assay and the SNPs resuspended in YPD medium containing C. albicans (1×10.sup.5 cells/ml), TSY medium containing S. aureus or E. coli (1×10.sup.6 cells/ml), or distilled water containing spores (1×10.sup.6 spores of A. oryzae or P. ochrochloron). The suspension was incubated in an orbital shaker for 6 h at 30° C. (fungi and molds) or 37° C. (bacteria) and the number of CFU was determined as described above.
[0114] Growth kinetics of C. albicans, S. aureus and E. coli (1×10.sup.5 cells/ml) exposed to variable concentrations of DDAB.sub.250-SNP5 or DDAB.sub.250-SNP80 (from 3.1 to 50 μg/ml for fungi and S. aureus and from 150 to 1000 μg/ml for E. coli) were evaluated by absorbance at 600 nm. Inoculum corresponds to prokaryotic cells incubated without SNPs. The samples were prepared as described above.
[0115] As described above, after 6 h of exposure an aliquot of the cell suspension was plated on agar plates for 18 h and the number of yeast, bacteria or mold colonies was counted (
[0116] The MIC for SNP5-DDAB.sub.250 against C. albicans, S. aureus, and E. coli was 25, 12.5 and 500 μg/ml, respectively, while for SNP80-DDAB.sub.250 was 50, 25 and above 1000 μg/ml (Table 4). At these concentrations, coated SNP5 formulations have 4.5, 2.2 and 89.1 μg of DDAB, while SNP80 have 9.7, 4.9 and 194.4 μg of DDAB, respectively (Table 4). Importantly, with the exception of MIC values obtained against E. coli, the MIC values of SNPs coated with DDAB are much below the MIC of DDAB solutions (C. albicans: 125 μg/ml; S. aureus 31.25 μg/ml; E. coli 125 μg/ml).
[0117] To assess the relative contributions from surfactant release and SNP killing, SNP80-DDAB.sub.250 were incubated in YPD or TSY mediums or distilled water for 6 h, centrifuged and the supernatant collected and tested against microorganisms. Limited killing was observed (below 25%) suggesting that antimicrobial activity of the SNPs is mainly mediated by contact (
Example 9: Antimicrobial Activity of SNP-DDAB Over Time
[0118] The antimicrobial activity of DDAB.sub.250-SNP80 over time was evaluated as follows. Samples of DDAB.sub.250-SNP80 (1 mg/ml) were maintained in 0.1 M citrate/sodium citrate buffer pH 3.0, PBS pH 7.4, 0.1 M borate/NaOH buffer pH 9.0 and YPD medium for 60 days. The buffers and the YPD medium were changed every 3 days. For that purpose, SNPs were centrifuged at 14,000 rpm for 20 min, and the buffer/medium replaced by a new one. After 60 days, the SNPs were centrifuged (same conditions as before), washed with distilled water, and freeze-dried before testing antifungal activity with C. albicans (1×10.sup.5 cells/ml). After an incubation of 6 h, an aliquot of the medium was serially diluted in distilled water and plated in agar to assess the number of microorganisms. The results are shown in
[0119] Similar tests were performed with bacteria (E. coli and S. aureus) and molds (A. oryzae and P. ochrochloron) and the results are shown in
Example 10: Antimicrobial Activity of SNPs and SNP-DDAB Coated on Glass Coverslips
[0120] The antimicrobial activity due to the leaching of the SNPs was evaluated by washing the glass coverslips (sterilized for 30 min under UV light) coated with SNP5 and SNP5-DDAB.sub.250 for 6 h with 1 ml of YPD (at 30° C.) or TSY (at 37° C.), under orbital shaking (150 rpm). The washing medium was tested against 1×10.sup.5 C. albicans cells, 1×10.sup.6 E. coli or S. aureus cells. No measureable antimicrobial activity was detected (
[0121] After confirming the absence of antimicrobial activity in the washing solutions, the antimicrobial activity of the surfaces was tested by adding 1 ml of YPD with 1×10.sup.5 C. albicans cells or 1 ml of TSY with 1×10.sup.3 E. coli or 1×10.sup.6 S. aureus cells to each coverslip and incubating at 30° C. (fungi) or 37° C. (bacteria) for 6 h, under orbital shaking (150 rpm). An aliquot of the medium was serially diluted in sterile distilled water and plated on YPD or TSY agar plates. The number of CFU was counted after incubation of the plates at 30° C. or at 37° C. for 24 h. The remaining medium was removed and the coverslips were rinsed twice with 1 ml of sterile water. After drying rapidly, the coverslips were plated with coated side down on YPD or TSY agar plates and incubated at 30° C. or at 37° C.
[0122] A 100% reduction in C. albicans, E. coli and S. aureus was observed in the media containing the coverslips coated with SNP5-DDAB.sub.250 relative to the control (coverslips coated with SNP5). Finally, the remaining medium was removed and the coverslips were rinsed with sterile water to remove non-adherent cells and plated upside down on YPD or TSY agar plates. After 24 h, no C. albicans, E. coli or S. aureus colonies were observed on the coverslips coated with SNP5-DDAB.sub.250, whereas fungi and bacteria colonized the control coverslips coated with SNP5 (
Example 11: Dynamic Light Scattering (DLS) Analysis of DDAB-SNP and DDAB-SNP80
[0123] The size of the coated SNPs were determined using dynamic light scattering (DLS) as described in Example 1.2.3. The results of this analysis are shown in Table 4.
TABLE-US-00004 TABLE 4 MIC (μg/ml).sup.b SNPs Size (nm).sup.a C. albicans S. aureus E. coli SNP5 7.5 ± 1.7 — — — SNP5-DDAB 34.6 ± 13.5 25 (4.5) 12.5 (2.2) 500 (89.1) SNP80 78.9 ± 12.6 — — — SNP80-DDAB 98.5 ± 6.0 50 (9.7) 25 (4.9) >1000 (194.4) .sup.aData corresponds to the average ± standard deviation of three independent measurements by DLS. .sup.bThe value in parentheses is the amount of DDAB (μg) in the SNPs.
Example 12: Assessment of Antiviral Activity
[0124] MDCK cells obtained from the European Collection of Cell Cultures agency (ECACC), were grown in Dulbecco's Modified Eagle's Medium supplemented with 10% fetal bovine serum (FBS), 100 units/ml penicillin and 100 μg/ml streptomycin, at 37° C. in a humidified-air atmosphere containing 5% CO.sub.2. Influenza A/PR/8/34 (H1N1) was obtained from Advanced Biotechnologies.
[0125] The antiviral activity of the coated glass coverslips was assessed by a methodology described in Halder et al. ‘Preparation, application and testing of permanent antibacterial and antiviral coatings’. Nat. Protoc 2007 (2) 2412-2417. Briefly, glass coverslips (glass, glass dopamine coated with SNP5 and glass dopamine coated with SNP5-DDAB.sub.250) were placed in 24-well plates and 20 μl of virus solution was deposited on the top of each sample and covered with parafilm to spread the drop. After 30 min. of incubation at room temperature, the samples were washed with 1.98 ml PBS and 2-fold serial dilutions were made. Then, confluent MDCK monolayers were washed twice with PBS and infected with 200 μl of each dilution for 1 h at room temperature. After incubation, the virus solution was aspirated and the cells were covered with agar medium (1:1 DME/F12 modified supplemented with 0.01% DEAE-dextran, 0.1% NaHCO.sub.3, 4 μg/ml trypsin, 100 units/ml penicillin, 100 μg/ml streptomycin and 0.6% agar) and incubated for 4 days at 37° C. in a humidified-air atmosphere containing 5% CO.sub.2. Finally, the agar overlay was removed and the cells were fixed with paraformaldehyde and stained with crystal violet (0.1% in 20% v/v aqueous methanol).
[0126] The antiviral activity of the surfaces due to the leaching of SNPs was evaluated by washing the coverslips with PBS (1 ml) for 6 h under orbital shaking and incubating the washing with 20 μl of virus solution for 1 h at room temperature. The number of viral colonies was determined as before.
[0127] No measurable antiviral activity was observed (
Example 13: Physical Immobilization of Surfactants on CNT
[0128] SWCNT were chosen for use in this study as they have been shown to exhibit antimicrobial activity (Kang et al. ‘Single-walled carbon nanotubes exhibit strong antimicrobial activity.’ Langmuir 2007 (23) 8670-8673) which is stronger than for MWCNTs (Arias et al. ‘Inactivation of Bacterial Pathogens by Carbon Nanotubes in Suspensions. Langmuir 25 (2009) 3003-3012) Carboxylated single-wall carbon nanotubes of 1.5 nm in diameter and 1-5 m in length (>95% purity; 2-7 wt % COOH by titration) were purchased from NanoLab (USA) and used without further processing. SWCNTs and DDAB (Sigma-Aldrich) were mixed in a mass ratio from 0.1 to 100 (e.g. 1500 μg/ml DDAB is mixed with 100 μg/ml SWCNT suspension yielding a mass ratio of 15) in PBS and then sonicated. A 6 mm probe was used with sonication cycles of 1 h with 5:1 seconds of pulse (on:off).
[0129] The amplitude used was typically 50%. After each cycle the released energy was registered and the optical density at 600 nm was measured. Typically, centrifugation cycles were performed on a centrifuge at 10,000 g for 20 min, to remove the aggregates.
Example 14: Characterization of the SWCNT
[0130] The evolution of SWCNTs resuspension was performed by optical density measurement (at 600 nm) on a microplate reader. N-phenyl-1-naphthylamine (NPN) (Sigma-Aldrich) was used to determine the DDAB critical micelle concentration (CMC) and the presence of micelles on the SWCNT suspension. A solution of NPN of 2×10-M in ethanol was prepared and further diluted in PBS to the working concentration of 2×10.sup.−4 M. DDAB or SWCNT-DDAB suspensions were mixed in equal volumes on a opaque 96-well plate and the fluorescence measured with the assistance of a SpectraMax Fluoremeter using an excitation and emission wavelength of 320 and 450 nm, respectively.
[0131] In order to be able to accurately assess the antimicrobial activity of SWCNT:DDAB it was imperative to determine whether free surfactant was co-existing in solution with the complex SWCNT:DDAB. A centrifugation step to separate SWCNT:DDAB from free DDAB is not a reliable methodology since it requires extensive centrifugation velocities and the nanotubes tend to aggregate. It was observed that increasing the mass ratios of DDAB to SWCNTs from 2.5 to 100 decreased substantially the recovered pellet (
[0132] This result suggests the disappearance of the existing micelles on the DDAB starting solution and the avidity of DDAB for SWCNTs. Tests also confirmed that sonication, up to 10,000 joules, did not disrupt the micelles, confirmed by persistence of the fluorescence levels (results not shown). Overall results indicated that most of the DDAB initially added to SWCNTs was adsorbed to the surface of the nanotube.
Example 15: Preparation of Alginate Microparticles
[0133] Alginic acid and calcium chloride were purchased from Sigma-Aldrich. Calcium-alginate microparticles were prepared at room temperature with a Nisco Nozzle Var-J1 (Nisco, Switzerland) and coaxial nitrogen air flow. Briefly, an alginate solution (0.5-2%) was extruded with controlled flow (10-200 ml/h) through a variable internal diameter needle (ID˜200-450 μm). The controlled coaxial flow of nitrogen (0.5-15 L/min) cuts the alginate flow on the other edge of the needle, projecting the alginate drop against a calcium chloride solution of variable concentration (0.05-1 M) with or without magnetic stirring. The needle length (1-5 mm) and nozzle height (2-20 cm) to the calcium solution were also screened. Each sample was visualized and photographed under the contrast phase microscope and the sizes were assessed with ImageJ.
Example 16: Preparation of Alginate Micoparticle-DDAB-SWCNT Composite
[0134] Magnetic nanoparticles were acquired from PlasmaChem (Germany). To prepare the alginate microparticles-loaded with DDAB-SWCNT and magnetic nanoparticles defined standard concentrations for each of the components were determined. The typical extruded composite suspension is composed of 2% alginate, 10-100 μg/ml of magnetic nanoparticles (PlasmaChem, Germany), 25 μg/ml of SWCNT and DDAB. The latter amount depends on the DDAB/SWCNT mass ratio chosen. This mix was typically extruded against a 0.1 M CaCl.sub.2) solution at a flow rate of 10-20 ml/h (needle with 200 μm i.d.) or 50-100 ml/h (needle with ˜420 μm i.d.). A nitrogen coaxial flow rate of 5-8 l/min was used to generate beads.
Example 17: Assessment of Antimicrobial Activity
[0135] Typically, SWCNTs coated with DDAB or other surfactants were diluted taking in account the initial surfactant concentration being the SWCNT concentration estimated by the corresponding mass ratio used. The antimicrobial activity of the coated SWCNTs was tested in suspension against Candida albicans ATCC 10231 (C. albicans, fungi), Staphylococcus aureus ATCC 6538 (S. aureus, bacteria gram-positive) and Escherichia coli ATCC 25922 (E. coli, bacteria gram-negative). Yeast Peptone Dextrose (YPD) and Tryptone Soy Yeast (TSY) media were used to culture yeast and bacteria, respectively.
[0136] Growth kinetics of the different microorganisms (1×10.sup.5 cells/ml) exposed to variable concentrations of DDAB-SWCNT suspended in PBS (500-0.3 μg/ml of DDAB which corresponds to a 33-0.002 and to a 5-0.0003 μg/ml of SWCNT under a mass ratio of 15 and 100, respectively) was evaluated by absorbance at 600 nm. Inoculum corresponds to cells incubated without CNTs. The samples were prepared in a 96-well plate and incubated for 18 h at 30° C. (fungi) or 37° C. (bacteria) with constant shaking in a Biotek Synergy Mx spectrophotometer.
[0137] DDAB-SWCNTs (mass ratio of DDAB:SWCNT) of 15 and 100 showed high antimicrobial activity against C. albicans, S. aureus and E. coli, exhibiting minimal inhibitory concentrations (MIC) of approximately 2, 0.5 and 31 μg/ml, respectively (Table 4). These MIC values compare favourably to the ones obtained for silica nanoparticles coated with DDAB. Also, these values compare favourably to the ones reported in the literature using CNTs. The lowest concentration ever reported for an effective antimicrobial activity of SWCNTs in suspension (although in this case forming aggregates) was 1 μg/ml (Kang et al. ‘Single-walled carbon nanotubes exhibit strong antimicrobial activity’. Langmuir 2007 (23) 8670-8673).
TABLE-US-00005 TABLE 4 MIC of complexed DDAB DDAB- MIC (μg/ml) SWCNT C. albicans S. aureus E. coli (mass ratio) DDAB SWCNT DDAB SWCNT DDAB SWCNT SNP5- 4.5 — 2.2 — 500 — DDAB.sub.250 SNP80- 9.7 — 4.9 — 194.4 — DDAB.sub.250 SWCNT.sub.15- 7.8 0.5 1.95 0.13 31 2 DDAB SWCNT.sub.100- 2 0.02 0.5 0.005 31 0.31 DDAB
[0138] Advantageously, DDAB acts simultaneously as a dispersant agent of the SWCNTs and as an antimicrobial agent.
[0139] It is apparent that the antimicrobial complexes of the invention demonstrate effective antimicrobial activity both in suspension and when immobilized on surfaces. The surfactants exhibit low minimal inhibitory concentrations compared with soluble surfactants. Thus, the complexes of the invention can be used to prepare highly active antimicrobial coatings with a broad spectrum of activity. The inventors have shown that when the nanomaterial complexes are applied to a surface, a non-leaching surface coating is obtained such that a long-lasting antimicrobial effect can be achieved.
[0140] The invention also encompasses methods of preparing the nanomaterial complexes and of applying the complex to a surface to create an antimicrobial coating.